 |
| Sarah McCabe |
JPA Health has hired Sarah McCabe to helm its newly launched investor relations practice.
She has more than 20 years of financial communications experience, which includes a 15-year stint at Stern Investor Relations. She was managing director at Stern.
The JPA IR unit will target companies in the pharmaceutical, biotechnology, and medical device sectors.
Carrie Jones, CEO of JPA, said investor relations “was a missing piece of the puzzle for our life sciences offerings, and we are delighted to now provide this capability to support our clients’ success.”
McCabe will report to Colleen Carter, head of the life sciences group.
JPA Health ranks No. 12 in O’Dwyer’s rankings of healthcare firms with 2023 fees of $24.3M.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
